Jupiter Neurosciences regains Nasdaq compliance for minimum share price

3 hours ago 1

Healthcare

Jupiter Neurosciences has regained compliance with Nasdaq's $1 minimum bid price rule.
Nasdaq confirmed that JUNS stock maintained a $1.00+ average closing price from June 18 to July 8, 2025.
Nasdaq now considers the compliance matter closed, allowing JUNS to maintain its listing.
Source: Press release

More on Jupiter Neurosciences, Inc.

Recommended For You

More Trending News

Read Entire Article